With a one year PEG ratio of 1,520.79, Fulgent Genetics Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 97.25% of US stocks.
Price to trailing twelve month operating cash flow for FLGT is currently 110.54, higher than 97.15% of US stocks with positive operating cash flow.
With a price/sales ratio of 18.45, Fulgent Genetics Inc has a higher such ratio than 91.88% of stocks in our set.
Stocks that are quantitatively similar to FLGT, based on their financial statements, market capitalization, and price volatility, are EPAY, WIX, PSTG, DMRC, and FEYE.
Fulgent Genetics, Inc., a technology company, focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is based in Temple City, California.
Today's headlines need not be tomorrow's storyline." - Craig D. Lounsbrough Today, we look at a name that fell back into 'Busted IPO' territory at the end of COVID-19 meltdown. The shares have popped back sharply since then, like so many equities over the past several months. Should investors be...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Altimmune Inc (NASDAQ: ALT ) (announced positive preclinical data for its intranasal vaccine candidate AdCOVID) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) (reacted to preliminary second-quarter results) Beigene Ltd (NASDAQ: BGNE ) - announced $421 million in additional investment by Amgen, Inc. (NASDAQ: AMGN ) in a $2.1-billion direct offering by the Chinese biotech BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Catalent Inc (NYSE: CTLT ) DexCom, Inc. (NASDAQ: DXCM ) Equillium Inc (NASDAQ: EQ (announced po...
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. In this article, we look at what those funds think […]